S1 Mistafa, O., et al. (2010) Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases. The Journal of biological chemistry 285, 27900-27910

S2 Lin, H.K., et al. (2004) Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. Mol Endocrinol 18, 2409-2423

S3 Fan, C., et al. (2009) PTEN inhibits BMI1 function independently of its phosphatase activity. Molecular cancer 8, 98

S4 Crockett, D.K., et al. (2005) Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics. Proteomics 5, 1250-1262

S5 Caselli, A., et al. (2002) Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochemical and biophysical research communications 296, 692-697

S6 Shen, W.H., et al. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157-170

S7 Sotelo, N.S., et al. (2012) A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains. Journal of cellular biochemistry 113, 2661-2670

S8 Adey, N.B., et al. (2000) Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer research 60, 35-37

S9 Lu, D., et al. (2011) Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression. Gastroenterology 140, 2084-2094

S10 Gorbenko, O., et al. (2010) Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4. Molecular and cellular biochemistry 337, 299-305

S11 Yang, C., et al. (2013) PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha. Molecular cancer 12, 21

S12 Okahara, F., et al. (2004) Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. The Journal of biological chemistry 279, 45300-45303

S13 Jurado, S., et al. (2010) PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression. The EMBO journal 29, 2827-2840

S14 Gunaratne, J., et al. (2011) Protein interactions of phosphatase and tensin homologue (PTEN) and its cancer-associated G20E mutant compared by using stable isotope labeling by amino acids in cell culture-based parallel affinity purification. The Journal of biological chemistry 286, 18093-18103

S15 Valiente, M., et al. (2005) Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. The Journal of biological chemistry 280, 28936-28943

S16 Lin, M.C., et al. (2012) PTEN interacts with metal-responsive transcription factor 1 and stimulates its transcriptional activity. The Biochemical journal 441, 367-377

S17 Yu, Z., et al. (2002) PTEN associates with the vault particles in HeLa cells. The Journal of biological chemistry 277, 40247-40252

S18 van Diepen, M.T., et al. (2009) MyosinV controls PTEN function and neuronal cell size. Nature cell biology 11, 1191-1196

S19 Howitt, J., et al. (2012) Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. The Journal of cell biology 196, 29-36

S20 Mund, T. and Pelham, H.R. (2010) Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2. Proceedings of the National Academy of Sciences of the United States of America 107, 11429-11434

S21 von Stein, W., et al. (2005) Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 132, 1675-1686

S22 Mahimainathan, L. and Choudhury, G.G. (2004) Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. The Journal of biological chemistry 279, 15258-15268

S23 Cao, J., et al. (2009) Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. The EMBO journal 28, 1505-1517

S24 Haier, J. and Nicolson, G.L. (2002) PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene 21, 1450-1460

S25 Tamura, M., et al. (1999) PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. The Journal of biological chemistry 274, 20693-20703

S26 Kim, Y.J., et al. (2011) PTEN modulates miR-21 processing via RNA-regulatory protein RNH1. PloS one 6, e28308

S27 Sanchez, T., et al. (2005) PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proceedings of the National Academy of Sciences of the United States of America 102, 4312-4317

S28 Yang, L., et al. (2011) Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression. Endocrinology 152, 4537-4549

S29 Hjelmeland, A.B., et al. (2005) Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. Cancer research 65, 11276-11281

S30 Mehenni, H., et al. (2005) LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Human molecular genetics 14, 2209-2219

S31 Ahmed, S.F., et al. (2012) The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. The Journal of biological chemistry 287, 15996-16006

S32 Gonzalez-Santamaria, J., et al. (2012) Regulation of the tumor suppressor PTEN by SUMO. Cell death & disease 3, e393

S33 Herlevsen, M., et al. (2007) A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer. Biochemical and biophysical research communications 352, 549-555

S34 Freeman, D.J., et al. (2003) PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer cell 3, 117-130

S35 Zhou, M., et al. (2003) PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer research 63, 6357-6362

S36 Meuillet, E.J., et al. (2004) Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Archives of biochemistry and biophysics 429, 123-133